Laddar...

Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia

Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrogation for the presence of minimal/measurable residual disease (MRD) by molecular genetic and/or flow cytometric techniques. Although ad...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood
Huvudupphovsmän: Hasserjian, Robert P., Steensma, David P., Graubert, Timothy A., Ebert, Benjamin L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2020
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225688/
https://ncbi.nlm.nih.gov/pubmed/32232484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004770
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!